Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

HHC and delta-9 THC are on different federal clocks. Under P.L. 119-103, the part of the new hemp redefinition that reaches cannabinoids not capable of being naturally produced by the cannabis plant starts November 12, 2026, while the rest, including the 0.4 mg total THC per container cap that governs hemp-derived delta-9, was pushed to December 11, 2026. HHC is the cannabinoid most exposed to the earlier date.
That is the short legal answer to "HHC vs THC" in late 2026. The longer answer depends on how you classify a product, because the same SKU can be affected by a DEA rule, by a state scheduling order, and by two separate federal dates at once.
HHC, or hexahydrocannabinol, is a hydrogenated cannabinoid. Commercial HHC is made in a lab by adding hydrogen to hemp-derived cannabinoids, usually starting from CBD. Delta-9 THC is the cannabinoid the 2018 Farm Bill used to define hemp, at no more than 0.3 percent on a dry-weight basis. This article makes no claims about potency or effects; those are testing and labeling questions, not legal ones.
The legal split turns on production method. Federal hemp law has long protected cannabinoids that come from the plant; it is far less clear about cannabinoids made by chemical conversion. Our piece on naturally derived versus synthesized cannabinoids covers the evidence standard for each side.
On May 4, 2026, the DEA published a final rule titled "Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance" (91 Fed. Reg. 23913; Docket DEA-1632). The rule gives HHC its own Schedule I listing, drug code 7220. In the rule, DEA says HHC was already controlled in Schedule I as a tetrahydrocannabinol under a different code, that the 2018 Farm Bill's hemp exclusion covers only THC from the plant, and that THC produced "through chemical conversion" does not qualify, even when derived from hemp. It describes the change as technical and skipped notice and comment. The rule cites the UN Commission on Narcotic Drugs' March 2025 decision to place HHC under the 1971 Convention on Psychotropic Substances.
Two hemp companies have challenged the rule: IHC Investments in the Ninth Circuit and Bluestar Operations in the Fourth. As reported by Marijuana Moment, the Fourth Circuit denied Bluestar's request for a stay in June, and the DEA's August 11 brief argues Bluestar lacks standing and that HHC is synthetic. No merits ruling has been reported. Our coverage of the HHC Schedule I lawsuit tracks the filings.
| Item | HHC | Hemp-derived delta-9 THC |
|---|---|---|
| Origin | Hydrogenated in a lab from hemp-derived cannabinoids | Occurs in the plant |
| Federal position today | DEA lists it in Schedule I (May 4, 2026 rule); challenged in two circuits | Hemp if the product meets the 0.3 percent delta-9 test; federal redefinition pending |
| November 12, 2026 | First phase reaches cannabinoids not capable of being naturally produced by the plant | Not the first-phase target |
| December 11, 2026 | Also subject to the total-THC redefinition and exclusions | 0.4 mg total THC per container cap and total-THC redefinition begin |
| State treatment | Scheduled or restricted in some states, such as South Carolina | Varies widely by state and product form |
| Testing and labels | Documentation of process and sourcing matters | Total THC per container, including THCA, matters |
The open question is who decides what counts as "not capable of being naturally produced" by the cannabis plant. We checked the FDA's cannabis regulation page, which shows content current as of July 16, 2024, and it contains no list of such cannabinoids or reference to the 2026 hemp definition. Until a list or guidance appears, the November 12 line for any specific cannabinoid rests on interpretation. The court challenges could also change the picture.
States are not following one pattern. Illinois sets its own line: from November 12 it treats consumable hemp products above 0.4 mg total THC per container as cannabis, which is one reason HHC and delta-8 sellers should read Illinois's 2026 cannabis omnibus law and the state hemp deadlines. South Carolina went the scheduling route. Abroad, HHC is treated differently again; see HHC in the UK and Europe.
For neighboring comparisons, see HHC vs delta-8, THCA vs THC, delta-8 vs delta-9 and THC-P vs THC. The federal calendar is set out in our explainer on the federal hemp dates.
HHC is a hydrogenated cannabinoid made from hemp-derived compounds; delta-9 THC occurs naturally in the plant. Their legal treatment now diverges by federal date.
Both are affected by the federal hemp redefinition. THCA counts toward total THC on December 11, while HHC is exposed to the earlier November 12 phase. State law varies.
The DEA says HHC is in Schedule I and that position is being challenged in court. Federally, the first phase of the hemp redefinition reaches cannabinoids not capable of being naturally produced from November 12, 2026, and many states restrict HHC. Check your state.
The DEA's May 2026 rule describes HHC as synthetic; the companies challenging it say it is a hemp derivative protected by the 2018 Farm Bill. A court has not resolved the question.
That is not a legal question. Potency claims belong in product testing and should not appear in marketing without counsel's review.
This is regulatory journalism, not legal advice — talk to your counsel.